The results speak for themselves
Existing GLP1R agonists come with boxed warnings of thyroid cancer and pancreatitis, based mainly on rodent studies, where the effects of GLP1R agonism have noted species differences (For example, weight loss in rodents is mainly due to increased energy expenditure, whereas in humans it occurs via less food intake [54] )
By pairing evidence-based medicine with a deeply human approach, Ro strives to help patients feel seen, supported, and empowered to take control of their weight in a way theyve never been able to before. On Ro, you can get access to some of the most effective GLP-1 medications approved by the US Food and Drug Administration (FDA) alongside structured, ongoing care from a licensed provider
Compounded semaglutide lacks the proprietary stabilizers found in brand-name products and is generally less tolerant of room temperature exposure
For many, the GLP-1 journey involves experimentation: adjusting doses, changing drugs, or moving between branded and compounded options in search of something tolerable